Asthma guidelines update CTS and GINA

This program is supported in part by an educational grant from AstraZeneca. 

Please join for a virtual program on optimizing anti-inflammatory reliever therapy a fundamental change in approach to treating Asthma. 

Speakers:

• Dr. Amanda Jagdis, Allergist 
• Dr. Walter Chow, Family Physician - moderator 

Learning objectives:

• Describe the latest asthma treatment recommendations from the Global, Initiative for Asthma (GINA) and the Canadian Thoracic Society (CTS)
• Discuss why over-reliance on short-acting beta-agonists (SABA) increases risk of exacerbations and worsening asthma
• Discuss recent evidence on anti-inflammatory reliever reducing asthma exacerbations
• Identify strategies to transition patients from SABA as a reliever to anti-inflammatory reliever

How to join:

• Registration required: https://us02web.zoom.us/meeting/register/tZ0kce2qqDItGNEquxUm4kpLC6JD5aeU1BIv
• Zoom ID: 899 6426 9725
• Password: 688652
• Questions: contact Shaun Banser, cell: 250-801-7666 or email: shaun.banser@astrazeneca.com

CME: This activity has been certified for up to 1.0 Mainpro+ credits.

Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.